116 related articles for article (PubMed ID: 34697184)
1. The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer.
Aoyama T; Nakazono M; Segami K; Nagasawa S; Kano K; Yamada T; Maezawa Y; Hara K; Hashimoto I; Suematsu H; Watanabe H; Takahashi K; Numata M; Tamagawa H; Yukawa N; Rino Y; Ogata T; Oshima T
In Vivo; 2021; 35(6):3475-3482. PubMed ID: 34697184
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Nakazono M; Segami K; Nagasawa S; Kano K; Hara K; Maezawa Y; Hashimoto I; Suematsu H; Watanabe H; Komori K; Tamagawa H; Yukawa N; Rino Y; Ogata T; Oshima T
J Gastrointest Cancer; 2023 Mar; 54(1):27-34. PubMed ID: 34921671
[TBL] [Abstract][Full Text] [Related]
3. The Association of the Lymphocyte-to-C-Reactive-Protein Ratio With Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Nakazano M; Nagasawa S; Hara K; Komori K; Tamagawa H; Maezawa Y; Segami K; Kano K; Ogata T; Yukawa N; Rino Y; Oshima T
In Vivo; 2022; 36(1):482-489. PubMed ID: 34972752
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment.
Aoyama T; Komori K; Nakazano M; Hara K; Tamagawa H; Kazama K; Hashimoto I; Yamada T; Maezawa Y; Segami K; Kano K; Nagasawa S; Yukawa N; Rino Y; Ogata T; Oshima T
In Vivo; 2022; 36(2):942-948. PubMed ID: 35241553
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kawahara S; Cho H; Morita J; Segami K; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
J Gastrointest Cancer; 2024 Mar; 55(1):383-390. PubMed ID: 37784000
[TBL] [Abstract][Full Text] [Related]
6. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.
Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M
Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124
[TBL] [Abstract][Full Text] [Related]
7. The clinical impacts of lymphocyte-to-C-reactive protein ratio for esophageal cancer patients who receive curative treatment.
Aoyama T; Nagasawa S; Nakazono M; Segami K; Tamagawa H; Tamagawa A; Hara K; Oshima T; Yukawa N; Masuda M; Rino Y
J Cancer Res Ther; 2023; 19(3):556-561. PubMed ID: 37470574
[TBL] [Abstract][Full Text] [Related]
8. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
[TBL] [Abstract][Full Text] [Related]
9. The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Ozawa Y; Maezawa Y; Kano K; Murakawa M; Kazama K; Segami K; Hara K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
In Vivo; 2020; 34(5):2783-2790. PubMed ID: 32871815
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer: A systematic review and meta-analysis.
Yang X; Song X; Zhang L; Wu C
Medicine (Baltimore); 2020 Mar; 99(10):e19362. PubMed ID: 32150079
[TBL] [Abstract][Full Text] [Related]
12. Preoperative C-reactive protein-to-albumin ratio and clinical outcomes after resection of colorectal liver metastases.
Sakamoto Y; Mima K; Imai K; Miyamoto Y; Tokunaga R; Akiyama T; Daitoku N; Hiyoshi Y; Iwatsuki M; Nagai Y; Baba Y; Iwagami S; Yamashita YI; Yoshida N; Baba H
Surg Oncol; 2020 Dec; 35():243-248. PubMed ID: 32932221
[TBL] [Abstract][Full Text] [Related]
13. Clinical Burden of C-Reactive Protein/Albumin Ratio Before Curative Surgery for Patients with Gastric Cancer.
Toiyama Y; Shimura T; Yasuda H; Fujikawa H; Okita Y; Kobayashi M; Ohi M; Yoshiyama S; Hiro J; Araki T; Inoue Y; Mohri Y; Kusunoki M
Anticancer Res; 2016 Dec; 36(12):6491-6498. PubMed ID: 27919972
[TBL] [Abstract][Full Text] [Related]
14. Value of the CRP-albumin ratio in patients with resectable pancreatic cancer.
Arakawa Y; Miyazaki K; Yoshikawa M; Yamada S; Saito Y; Ikemoto T; Imura S; Morine Y; Shimada M
J Med Invest; 2021; 68(3.4):244-255. PubMed ID: 34759138
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients.
Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
World J Surg; 2018 Jun; 42(6):1819-1825. PubMed ID: 29270656
[TBL] [Abstract][Full Text] [Related]
17. [The value of spleen density in predicting prognosis of patients with gastric cancer after curative gastrectomy].
Li S; Ma PF; Zhang JL; Cao YH; Liu CY; Zhang XJ; Li ZY; Xue YW; Zhao YZ
Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(34):2703-2709. PubMed ID: 34510877
[No Abstract] [Full Text] [Related]
18. Prognostic significance of the preoperative C-reactive protein-to-albumin ratio in patients with colorectal cancer.
Tamagawa H; Aoyama T; Numata M; Maezawa Y; Kazama K; Astumi Y; Hara K; Kano K; Yukawa N; Saeki H; Godai T; Oshima T; Goda M; Rino Y; Masuda M
J Cancer Res Ther; 2021; 17(4):1075-1080. PubMed ID: 34528567
[TBL] [Abstract][Full Text] [Related]
19. The clinical impacts of the prognostic nutritional index for the esophageal cancer patients who received curative treatment.
Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Maezawa Y; Kano K; Murakawa M; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
J Cancer Res Ther; 2023 Dec; ():. PubMed ID: 38102916
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
